• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® RUB IGG II - 30221

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® RUB IGG II - 30221 Back to Search Results
Catalog Number 30221
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in (b)(6) notified biomérieux of obtaining a false negative result for a patient sample in association with the vidas® rub igg ii 60 tests (ref.30221, lot 1007517570).The customer stated the patient was a pregnant woman who was confirmed to be positive for rubella igg one month prior.The sample was initially tested using vidas® rub igg lot 1007517570, and obtained a negative result of 0 iu/ml.The customer tested the sample two additional times, both repeat tests yielded positive results of 223 ui/ml and >400 ui/ml.Although repeat testing resulted in a one (1) day delay in reporting results, the customer confirmed the correct result of positive was reported to the treating physician.Biomérieux will initiate an internal investigation.
 
Manufacturer Narrative
An internal biomérieux investigation was performed for a customer complaint of false negative igg results when testing a patient sample with vidas® rubella igg assay (ref 30221, lot 1007517570).The customer did not submit the patient¿s sample for the investigation.Batch history: there is no capa nor non-conformity recorded on vidas rub igg ii ref.30221 linked to customer's issue batch history records vidas rub igg ii ref.30221 lot 1007517570 showed no anomaly during the manufacturing, control and packaging processes linked to the customer's complaint.Complaint trend: no recurrence of the customer's issue for the impacted lot.Control charts: the complaint laboratory observed four (4) internal samples on seven (7) different batches of vidas rub igg ii ref.30221 including lot 1007517570.R181: 1 iu / ml; ranges [0-3] iu / ml; r237: 5 iu / ml; ranges [2-7] iu / ml; r100: 169 iu / ml; ranges [112-227] iu / ml; r180: 221 iu / ml; ranges [140-303] ui / ml.All results are within specifications; customer's lot is in the trend of the other lots.Tests performed: the complaint laboratory tested four (4) internal samples (r180 and three others) with retain kits of lot 1007517570.There was no anomaly; all values ¿¿for each sample were within specification.The complaint laboratory performed two (2) additional tests without sample and without spr.Without sample or without spr the result is negative with 0rfv.Conclusion: no anomaly was highlighted with the control chart analysis and the analysis of quality data.Hypothesis: as customer's issue was reproduced when performing analysis without sample or spr, the negative result obtained by customer may be linked to an operator error.Without customer's return sample, this hypothesis cannot be confirmed and we cannot pursue further investigation.The investigation concluded vidas rub igg ii ref.30221 lot 1007517570 is within the expected performance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® RUB IGG II - 30221
Type of Device
VIDAS® RUB IGG II - 30221
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile 69280
FR  69280
MDR Report Key9595569
MDR Text Key207750259
Report Number8020790-2020-00003
Device Sequence Number1
Product Code LFX
Combination Product (y/n)N
PMA/PMN Number
K141133
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 03/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/24/2020
Device Catalogue Number30221
Device Lot Number1007517570
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/17/2019
Initial Date FDA Received01/16/2020
Supplement Dates Manufacturer Received02/19/2020
Supplement Dates FDA Received03/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-